Royal Bank Of Canada Merck & Co., Inc. Call Options Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $6.67 Million - $7.74 Million	60,000 New	60,000 $6.81 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $23.6 Million - $26.3 Million	-228,900 Reduced 49.97%	229,200 $24.4 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $15.6 Million - $20 Million	178,100 Added 63.61%	458,100 $50.8 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $14.3 Million - $16 Million	-168,700 Reduced 37.6%	280,000 $24.1 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $32.7 Million - $37 Million	391,200 Added 680.35%	448,700 $40.9 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $4.9 Million - $5.5 Million	-66,700 Reduced 53.7%	57,500 $4.72 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $57,824 - $72,432	-800 Reduced 0.64%	124,200 $9.52 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $8.96 Million - $9.85 Million	125,000 New	125,000 $9.39 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.